Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
The employees received, in the aggregate, non-qualified stock options to purchase 100,800 shares of Adicet’s common stock with an exercise price of
All of the above-described awards were granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan, which was adopted by the board of directors in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220603005017/en/
Investor and Media Contacts
Stern Investor Relations, Inc.